封面
市場調查報告書
商品編碼
2019593

全球冠狀動脈支架市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Coronary Arteries Stent Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計冠狀動脈支架市場將從 2025 年的 103.4 億美元成長到 2034 年的 187.2 億美元,2026 年至 2034 年的複合年成長率為 6.82%。

由於心血管疾病發生率不斷上升,全球冠狀動脈支架市場正經歷強勁成長。冠狀動脈支架用於疏通阻塞的動脈,恢復血流,降低心肌梗塞的風險。人口老化和文明病發生率的上升是推動市場擴張的主要因素。此外,醫療技術的進步也提高了支架的性能和患者的治療效果。

關鍵成長要素包括微創手術的日益普及和藥物釋放型支架的研發。這些支架可降低血管再阻塞風險,並改善長期治療效果。醫療基礎設施的擴建和先進心臟治療的可近性提高也促進了市場成長。此外,人們對心臟健康和早期診斷意識的增強也支撐了市場需求。

冠狀動脈支架市場預計未來將顯著成長,這主要得益於心血管治療領域的持續創新。生物可吸收支架和新一代支架的研發將進一步加速其應用。隨著醫療保健體系的不斷完善,新興市場可望帶來巨大的成長機會。此外,持續的研發投入也將持續推動市場擴張。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球冠狀動脈支架市場:依產品類型分類

  • 市場分析、洞察與預測
  • 裸金屬支架
  • 藥物釋放型支架
  • 生物可吸收支架

第5章 全球冠狀動脈支架市場:依材料分類

  • 市場分析、洞察與預測
  • 金屬
  • 聚合物基

第6章 全球冠狀動脈支架市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 心臟中心

第7章 全球冠狀動脈支架市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Medtronic Plc
    • Biotronik SE & Co. KG
    • B. Braun Melsungen AG
    • Terumo Corporation
    • MicroPort Scientific Corporation
    • Biosensors International GroupLtd
    • Cook Medical Inc
    • CR BardInc
    • Elixir Medical Corporation
    • Stentys SA
    • Lepu Medical Technology(Beijing)Co.Ltd
    • Sahajanand Medical Technologies Pvt. Ltd
    • Meril Life Sciences Pvt. Ltd
簡介目錄
Product Code: VMR11216913

The Coronary Arteries Stent Market size is expected to reach USD 18.72 Billion in 2034 from USD 10.34 Billion (2025) growing at a CAGR of 6.82% during 2026-2034.

The global coronary arteries stent market is experiencing strong growth due to the increasing prevalence of cardiovascular diseases. Coronary stents are used to open blocked arteries and restore blood flow, reducing the risk of heart attacks. The growing aging population and rising incidence of lifestyle-related diseases are key factors driving market expansion. Additionally, advancements in medical technology are improving stent performance and patient outcomes.

Key growth drivers include the increasing adoption of minimally invasive procedures and the development of drug-eluting stents. These stents reduce the risk of restenosis and improve long-term outcomes. The expansion of healthcare infrastructure and increasing access to advanced cardiac care are also contributing to market growth. Furthermore, rising awareness about heart health and early diagnosis is supporting demand.

In the future, the coronary arteries stent market is expected to grow significantly with continuous innovation in cardiovascular treatments. The development of bioresorbable and next-generation stents will further enhance adoption. Emerging markets are likely to provide substantial growth opportunities due to improving healthcare systems. Additionally, ongoing research and development will continue to drive market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Bare Metal Stents
  • Drug-Eluting Stents
  • Bioabsorbable Stents

By Material

  • Metallic
  • Polymer-Based

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers

COMPANIES PROFILED

  • Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Biotronik SE Co KG, B Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Biosensors International Group, Ltd, Cook Medical Inc, C R Bard, Inc, Elixir Medical Corporation, Stentys SA, Lepu Medical Technology Beijing Co, Ltd, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CORONARY ARTERIES STENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Bare Metal Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drug-Eluting Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Bioabsorbable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CORONARY ARTERIES STENT MARKET: BY MATERIAL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Material
  • 5.2. Metallic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Polymer-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CORONARY ARTERIES STENT MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CORONARY ARTERIES STENT MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Material
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Material
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Material
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Material
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Material
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CORONARY ARTERIES STENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Boston Scientific Corporation
    • 9.2.2 Abbott Laboratories
    • 9.2.3 Medtronic Plc
    • 9.2.4 Biotronik SE & Co. KG
    • 9.2.5 B. Braun Melsungen AG
    • 9.2.6 Terumo Corporation
    • 9.2.7 MicroPort Scientific Corporation
    • 9.2.8 Biosensors International GroupLtd
    • 9.2.9 Cook Medical Inc
    • 9.2.10 C. R. BardInc
    • 9.2.11 Elixir Medical Corporation
    • 9.2.12 Stentys SA
    • 9.2.13 Lepu Medical Technology (Beijing) Co.Ltd
    • 9.2.14 Sahajanand Medical Technologies Pvt. Ltd
    • 9.2.15 Meril Life Sciences Pvt. Ltd